PROGRAM

Thursday 9th October 2025

0900 - 1215                                         
Workshop 1 - The Power of AI in Medicine & How to Get Started

AI is rapidly changing the way medical professionals access information, streamline tasks, and enhance patient care, but knowing where to begin can be challenging. This hands-on, interactive workshop is designed specifically for breast cancer specialists and industry practitioners seeking practical, safe ways to explore AI in their daily work.

Led by Pathfindr’s Laura Hatton (AI Educator & Facilitator) and Lindsay Page (AI Upskilling Lead), and
chaired by Dr. Daniel de Viana, the session will open with real-world insights from clinical practice, 
followed by live demonstrations of tools like ChatGPT, Microsoft Copilot and Heidi. You’ll explore AI through the lens of three core roles: Assistant, Thinker, and Creator, with clear medical use cases at each level. Expect practical guidance, open discussion on privacy and security, and plenty of space to experiment.

Bring your laptop, bring your questions, and get ready to try AI for yourself. No tech expertise required, just curiosity and a willingness to supercharge today and reimagine tomorrow.

Chair: Daniel de Viana                             
Lindsay Page,
Laura Hatton,
Daniel de Viana             
0900 - 1215
Workshop 2 - Updates in Radiation Oncology 
Topics
  • Fractionation and breast radiotherapy – What is the expert view on standard of care 2025?
  • Oncoplastic and Reconstruction – What are the radiotherapy implications for conserving surgery and mastectomy?
  • Volume delineation for breast radiotherapy - focus on partial breast and reconstructions (implants and tissue based)
  • Volume delineation  - potentials and pitfalls 
  • Treatment planning and delivery  
Chair: Susan Carroll
Orit Kaidar-Person,
Joseph Chan, Susan Carroll
0900 - 1215
Workshop 3 - Mastering Perforator Flaps in Breast Surgery: Principles, Techniques and Refinements 
Topics
  • Anatomy and vascular supply of perforator flaps 
  • Types of flap, indications and flap placement 
  • Video presentation: mark-up and US/doppler use 
  • Tips and tricks for chest wall perforator flap 
  • Modifications of LICAP flap
  • Getting started and pitfalls   
Chair: Peter Chin

Ashutosh Kothari, Peter      Barry, Farid Meybodi, Peter Chin                                     
0900 - 1215
Workshop 4 - Endocrine Deprivation in Breast Cancer Treatment: Managing the Fallout 
  • Management of Menopausal side effects and hormonal therapies to improve sexual health
  • Urinary concerns in Menopause 
  • Pelvic Physiotherapy approaches
  • Panel discussions
Chair: Jenny Gilchrist
Virginia Baird,
Mahesha Weerakoon, Daina Lazdins, Natasha  Keir,       Ashlee Stirling
1215 - 1315Lunch - for Workshop Attendees

1230 - 1315POSTER DISPLAY - AUTHORS PRESENT

1315Conference Opening and Welcome to country

1315 - 1530Session 1 - Hot Topics & Controversies in 2025 

Neoadjuvant systemic therapy and radiotherapy implications 2025 - what is the evidence?
Do anthracyclines still have a place in early breast cancer treatment?  
What the HER2?
Pushing the boundaries of breast conserving surgery  
The patient voice: unmet needs and realities of breast cancer treatment 

Shaping the Future of BreastScreen Australia: Insights from the National Policy and Funding Review
Chairs: Peter Chin, Maree Colosimo
Orit Kaidar-Person
Matteo Lambertini
Elena Provenzano
Ashutosh Kothari                          Emily Duncan, BCNA Seat at the Table                  
Vivienne Milch               
1600 - 1745           Session 2 - Wellbeing and Communication

KEYNOTE: When Words Matter: Communicating with the well-informed patient 
Hormone replacement in breast cancer patients: a controversy revisited  
Harnessing AI for Communication Excellence
Lessons, losses and hope: a Medical Oncologist reflects 
Q&A panel                                                                                                                                                                       
Chairs: Jenny Gilchrist, Susan Carroll
Lesley Fallowfield (Video)
Rhea Liang
Dawid Naude
Nicholas Wilcken        
1745 - 1915Social Function - Welcome/Networking Event  (Exhibition Area)   

Sponsored by
 
                                               

Friday 10th October 2025

0715 - 830                                                                Industry Breakfast Session
Title: Precision Medicine in Breast Cancer: Necessity or Hype?
International Guest Speaker: Prof Matteo Lambertini
Local Speakers: Dr Belinda Yeo (Chair), A/Prof Dhanusha Sabanathan, A/Prof Nirmala Pathmanathan, Ms Jenny Gilchrist 

Description: Be part of a lively breakfast session where your peers will debate the reality behind precision medicine in breast cancer. Australia stands at the forefront of global discussions around biomarker-driven therapies — raising urgent questions about when tailored treatments are truly necessary, and when they may be more hype than help.

Join international and local thought leaders as they tackle the latest evidence, explore the practical
challenges of implementation, and engage with the audience through dynamic case studies and
real-world scenarios. This session promises insights and debate for all members of the
multidisciplinary team — including medical oncologists, pathologists, clinical geneticists, surgeons, nurses, and allied health specialists — keen to shape the next chapter in breast cancer care.


0715 - 830Industry Breakfast Session
Title: Optimising outcome in oncoplastic and high risk patients
Speaker: Dr Chilton Chong (Breast Surgeon)



0845 - 1035Session 3 - Risk Assessment and screening strategies                                                                             

KEYNOTE: Talking about risk & uncertainty in genetic testing 
Next-Gen screening: a look at risk-stratified trials & protocols
Is hormone therapy safe for high-risk women without breast cancer?
Revolutionising BreastScreen: a year of live AI readings in NSW 
The Lancet Breast Cancer Commission - a roadmap for personalising breast cancer  prevention       
Q&A panel                                                                                                                                      
Chairs: Nick Repin, Jenny O'Sullivan 
Lesley Fallowfield (Video)        
Nehmat Houssami                         
Rhea Liang                                         
Matthew Warner-Smith                 
Kelly Anne Phillips                          
                                    
1100 - 1245 Session 4 - The Neoadjuvant multidisciplinary approach to management of breast cancer - the complexities              
Case Study 1 - Timing, sequencing and surgery: a complex case of high-risk breast cancer
Case Study 2 - Young and ER-Positive: navigating the challenges of endocrine therapy intolerance 
The pathological assessment of neoadjuvant treated breast cancer 
Preoperative endocrine therapy as a functional biomarker in ER+ breast cancer 
Q&A panel                 
Chairs: Sanjeev Kumar, Peter Barry
Tivya Kulasegaran 
Tivya Kulasegaran                        

Elena Provenzano   
Belinda Yeo                     
Matteo Lambertini, Ash Kothari. Elena  Provenzano,  Orit Kaidar-Person, 
Belinda Yeo, Owen Ung, Cameron Snell, Gillian Lamoury                                                                                                                                   
1245 - 1345Lunch in Trade Area

1245 - 1345
ASBD AGM

1300 - 1345POSTER DISPLAY - AUTHORS PRESENT

1345 - 1530Session 5  Rapid fire - Abstracts and oral presentations

KEYNOTE:  The young premenopausal woman the issues facing fertility, survivorship, pregnancy and genetic implications
Q & A
Oral Presentations
1. Current breast lesion localisation techniques used in Australia and New Zealand - a shift from hookwire localisation to wire-free devices.
2. Does preoperative Breast MRI overestimate tumour size?
3. Current trends in incidence and histopathological upgrade rates of Ductal Carcinoma in Situ (DCIS) and Atypical Ductal Hyperplasia (ADH) in Queensland
4. Balancing Costs and Care: A Retrospective Cost-Efficiency Analysis of Indeterminate (B3) Breast Lesion Management and the Role of Vacuum-Assisted Excision
Q & A
5. Changes in Treatment Recommendation for Patients with DCIS using a 7-Gene Predictive Biosignature: Analysis of the PREDICT Australia Study 
6. Breast sensation following nipple-sparing mastectomy versus breast-conserving surgery: a mixed-methods study.
7. Development and Validation of a Hybrid Artificial Intelligence Chatbot-Based Decision Support Aid for Personalised Breast Cancer Treatment Planning
8. Prehabilitation Program During Neoadjuvant Treatment for Breast Cancer (PROActiveB): Codesign and Feasibility Study
Q & A
Chairs: Cameron Snell, Sanjeev Kumar
Matteo Lambertini       



Susan Bell

Celina Ledgard
Isobel Hymer

Elizabeth Tan


Yvonne Zissiadis

Josette Mouawad

Chu Luan Nguyen

Susannah Graham
1600 - 1730Session 6 - Innovation and Advances

KEYNOTE: AI, Digital Biomarkers - integration of AI into breast cancer pathology
Smarter Surgery: Strategies to lower re-excision rates
Innovations in Imaging: The PET trial and next-generation PET modalities 
The therapeutic value of mainstream genetic testing 
Q&A panel
Chairs: Samriti Sood, Sandra O'Toole
Elena Provenzano
Ashutosh Kothari
Remy Lim
Annabel Goodwin 
1900 - 2300Conference Dinner - QT Hotel

Sponsored by
 

                                                      

Saturday 11th October 2025


0715 - 830          Industry Breakfast Session  
Title: Putting Patients First: Multidisciplinary strategies for managing adverse events in
patients treated with KEYTRUDA® (pembrolizumab) regimen in high-risk early stage TNBC
Speakers: Dr Maree Colosimo (Oncologist), Dr Lisa Ward (Endocrinologist), 
Dr Rebecca Moor (Oncologist)                  
                                                                                                                               
                                                                                              
0715 - 830                                                                                    
Industry Breakfast Session
Title: Bridging the Gap: A Multidisciplinary Morning on Regional and Remote Challenges in Breast Care 
Speakers: Dr Wendella Schimmer (Surgeon), Dr Nick Repin (Breast Radiologist), Dr Tuan Ha (Radiation Oncologist), Dr Virginia Baird (Women's Health GP), Stephanie Planner (Breast Sonographer)

Description: Join Siemens Healthineers for an engaging breakfast panel discussion bringing together leading experts from across the breast care continuum - including breast imaging, surgery, and radiation oncology - to explore the current landscape of breast disease management in Australia and New Zealand.

 This multidisciplinary panel will explore the unique challenges faced by patients and clinicians in remote and regional communities, along with emerging trends and technologies in breast care that have the potential to bridge the access gap and promote greater equity for everyone, everywhere, sustainably.  From disparities in access to leading technologies and workforce shortages, to diagnostic delays and infrastructure gaps, our panelists will share insights from the front lines and offer practical strategies to drive equitable outcomes across the healthcare system.

 This session promises thought-provoking discussion, cross-disciplinary perspectives, and a collaborative environment - over breakfast. Whether you're a clinician, policy maker, department administrator or healthcare innovator, this event offers a valuable opportunity to be part of the conversation shaping the future of breast care in our most underserved regions.


0845 - 1030Session 7 - Concurrent Sessions

7A Surgery and Radiotherapy  - Updates in Management                   
Global trends in training and practice of Oncoplastic Breast Surgery
Sentinel Node Mapping: options beyond Tc99
TAD talk: a practical review of Axillary De-escalation
Debate: The patients with residual axillary nodal disease after NAST should have complete Axillary Clearance                                               
Q&A panel  
                                                                                                                                             
7B Medical Oncology - Estrogen receptor positive disease                                                              

De-escalation in early HER2+ and TNBC: opportunities for tailored treatment 
HER2 is only half the story: the critical role of ER in HER2+ breast cancer 
What's next? Evolving treatment strategies after CDK4/6 inhibition progression                       
All CLEAR - a strategy aiming at zero deaths from breast cancer
Redefining phase 1: a first step, not a final hope                                                                                          
Q&A panel                                                                                                                                                                                                                              


Chair: Marie Burke, Daniel de Viana
Ashutosh Kothari
Peter Barry
Farid Meybodi
For surgery: Ashutosh  Kothari 
For radiotherapy: Orit Kaidar-  Person                                                                                                                                  Chairs: Maree Colosimo,      Sanjeev Kumar                                        
Belinda Yeo                                                 
Nicholas Wilcken 
Matteo Lambertini
Christine Chaffer
Dhanusha Sabanathan               
1100 - 1245Session 8 - Survivorship 

KEYNOTE: Key learnings from a  real-world survivorship clinic
Managing long term toxicities - bone matters
Managing long term toxicities - heart matters 
Lymphoedema & Musculoskeletal issues update
Nutrition, diets and supplements - navigating the plethora of information
Q&A panel                                                                                                                                                                    
Chairs: Angela Allen, Jenny Gilchrist                                                      Kim Kerin-Ayres                                    Mike Lin
Matthew Burrage                           
Robyn Box
Rewa Keegan                                   
1245 - 1330
Lunch in Trade Area
POSTER DISPLAY - AUTHORS PRESENT

1330 - 1500Session 9 - The last word on controversies panel                                                                                    

Are we overtreating the low-risk cancer? 
High breast density: what now?
Fibroepithelial lesions and predicting behaviour
Radiotherapy to implant reconstruction and after skin sparing mastectomy
Last chance questions - ask before it's too late!                                                                                           		Chairs: Maree Colosimo, Peter      Chin                                                              Orit Kaidar-Person                         
Nehmat Houssami                                  Sandra O'Toole
Orit Kaidar-Person                        
1515Conference Close                                                                                                                                                   Peter Chin & Maree Colosimo   

*Times are subject to change 

CONTACT US


Impact Events ABN 45 094 598 339 
Address: Unit 24, Level 3, 2 Brandon Park Drive, Wheelers Hill  Victoria 3150 Australia
Phone: 1300 061 814 or +61 3 8657 4987 Email: info@impactevents.com.au